Emeis Stock Drops 2.5% and Tests Support at €13.64 Again
The health services group's stock declines in an otherwise rising SBF 120. The stock briefly dips below its technical threshold before recovering, extending a sequence of volatile sessions. The movement occurs in a Parisian context marked by caution towards cyclical stocks.
The Stock Briefly Dips Below Its €13.64 Support Before Recovering
Emeis stock falls 2.5% to €13.65 in early afternoon trading, while the SBF 120 index is up 0.24%. The stock touched a session low of €13.61, momentarily dipping below its €13.64 support, before climbing back above. This movement extends the decline observed on Monday, already noted when the stock was among the biggest losers in the SBF 120. The price is currently below its three moving averages: MM20 at €14.12 (a gap of -3.33%), MM50 at €14.39, and MM200 at €13.97, indicating a short-term loss of momentum. The RSI at 42 remains neutral, with no extreme signals. Over one year, the performance remains positive at nearly 30%, but the stock has lost over 7% in the past month.
A Bearish Session in an Otherwise Bullish Parisian Market
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The stock's decline contrasts with the overall tone of the Paris market, with the CAC 40 up 0.35% and the SBF 120 up 0.24%. The European session remains fragile, however, with the DAX down nearly 1% and the VIX up more than 9% to 18.87 points, indicating a resurgence of nervousness imported from Wall Street, where the Nasdaq shows a marked decline. The overall environment continues to be influenced by the more restrictive turn of major central banks mentioned in an analysis on June 21, which weighs on valuations in sectors sensitive to interest rates. Operationally, Emeis has been under pressure for several sessions, with its price having tested a technical support in early June. The holding of the €13.64 threshold, retested this Wednesday, will be the next numerical reference to watch in the upcoming sessions.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
